Unity Technologies Grant 2021

MYND Therapeutics received a grant from Unity Technologies in 2021 to advance testing of their obesity digital therapeutic, with a specific focus on African American and Hispanic women in Houston, Texas.

The grant supported the development and pilot testing of MYNDSET's immersive therapeutic experiences built on the Unity platform. By targeting underserved communities disproportionately affected by obesity, MYND aimed to address critical health equity gaps in chronic disease management.

The pilot study, launched in March 2022, evaluated the effectiveness and cultural relevance of MYNDSET's VR/AR-delivered cognitive behavioral therapy among participants in the Houston area. The study design emphasized accessibility and engagement for populations that have historically had limited access to specialized obesity treatment programs.

The Unity Technologies grant program supports innovative projects that leverage real-time 3D technology to create positive social impact. MYND Therapeutics' selection reflects the potential of immersive digital therapeutics to transform healthcare delivery for diverse populations.